Literature DB >> 1854029

Cardiovascular actions of desflurane in normocarbic volunteers.

R B Weiskopf1, M K Cahalan, E I Eger, N Yasuda, I J Rampil, P Ionescu, S H Lockhart, B H Johnson, B Freire, S Kelley.   

Abstract

The cardiovascular actions of three concentrations of desflurane (formerly I-653), a new inhalation anesthetic, were examined in 12 unmedicated normocapnic, normothermic male volunteers. We compared the effects of 0.83, 1.24, and 1.66 MAC desflurane with measurements obtained while the same men were conscious. Desflurane caused a dose-dependent increase in right-heart filling pressure and a decrease in systemic vascular resistance and mean systemic arterial blood pressure. As measured by echocardiography, left ventricular end-diastolic area did not change except for a small increase at 1.66 MAC desflurane, and systolic wall stress was less at all concentrations of desflurane than during the conscious state. Desflurane did not change cardiac index or left ventricular ejection fraction. Heart rate did not change at 0.83 MAC, but progressively increased with deeper desflurane anesthesia. Stroke volume index was less at all concentrations of desflurane than while the men were conscious, but desflurane did not alter the velocity of ventricular circumferential fiber shortening. Mixed venous blood PO2 and oxyhemoglobin saturation were higher during all concentrations of desflurane anesthesia than during the conscious state. No volunteer developed a metabolic acidosis. We conclude that desflurane with controlled ventilation and constant PaCO2 causes cardiovascular depression, as indicated by the increased cardiac filling pressure and decreased stroke volume index and by no change in the velocity of circumferential fiber shortening in the presence of decreased systolic wall stress. However, cardiac output is well maintained, and heart rate does not increase at light levels of anesthesia. The cardiovascular actions of 0.83 and 1.66 MAC desflurane were also reexamined in 6 of the 12 men during the seventh hour of anesthesia. Prolonged desflurane anesthesia resulted in lesser cardiovascular depression than was evidenced during the first 90 min. The measures of cardiac filling (central venous pressure and left ventricular end-diastolic cross-sectional area) did not differ between the early and late periods of anesthesia. Systemic vascular resistance decreased further during the late period, but systolic wall stress did not differ between the two time periods. During the seventh hour of desflurane anesthesia, heart rate and cardiac index were higher at both anesthetic concentrations than during the first 90 min of anesthesia. Left ventricular ejection fraction and velocity of fiber shortening did not change with duration of desflurane anesthesia. Oxygen consumption, oxygen transport, the ratio of the two, mixed venous PO2, and mixed venous oxyhemoglobin saturation (SO2) increased late in the anesthetic in comparison with the first 90 min.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1854029

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  16 in total

1.  The effects of high-frequency jet ventilation (HFJV) on pneumoperitoneum-induced cardiovascular changes during laparoscopic surgery.

Authors:  A Bickel; A Trossman; I Kukuev; A Eitan
Journal:  Surg Endosc       Date:  2011-06-03       Impact factor: 4.584

Review 2.  Anesthesia.

Authors:  J Appleby; V A Lawrence
Journal:  J Gen Intern Med       Date:  1994-11       Impact factor: 5.128

Review 3.  Comparative tolerability profiles of the inhaled anaesthetics.

Authors:  J P Fee; G H Thompson
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

Review 4.  Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

5.  Pharmacokinetics of lidocaine delivered from a transmucosal patch in children.

Authors:  Andrea Leopold; Stephen Wilson; Joel S Weaver; Amr M Moursi
Journal:  Anesth Prog       Date:  2002

6.  Microcirculation measured by vascular occlusion test during desflurane-remifentanil anesthesia is superior to that in propofol-remifentanil anesthesia in patients undergoing thoracic surgery: subgroup analysis of a prospective randomized study.

Authors:  Youn Joung Cho; Jungil Bae; Tae Kyong Kim; Deok Man Hong; Jeong-Hwa Seo; Jae-Hyon Bahk; Yunseok Jeon
Journal:  J Clin Monit Comput       Date:  2016-09-26       Impact factor: 2.502

7.  Influence of desflurane, isoflurane and halothane on regional tissue perfusion in dogs.

Authors:  J C Hartman; P S Pagel; L T Proctor; J P Kampine; W T Schmeling; D C Warltier
Journal:  Can J Anaesth       Date:  1992-10       Impact factor: 5.063

Review 8.  Nitrous oxide and the inhalation anesthetics.

Authors:  Daniel E Becker; Morton Rosenberg
Journal:  Anesth Prog       Date:  2008

Review 9.  Desflurane. A review of its pharmacodynamic and pharmacokinetic properties and its efficacy in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

Review 10.  Desflurane clinical pharmacokinetics and pharmacodynamics.

Authors:  J E Caldwell
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.